Publications
21
Citations
143
Est. group size
~8
Recurring co-author estimate
Active years
11
Publishing since 2016
Sydney Fobare's research focuses on blood cancers, particularly acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL), studying the genetic mutations and molecular mechanisms that drive these diseases and influence treatment response. This work includes investigating specific gene mutations (such as PTPN11 and FLT3) and testing potential new drug therapies in laboratory models, with the goal of understanding disease progression and identifying better treatment strategies.
Publication output increased notably around 2021-2022 after a slower period earlier in the decade, and has continued at a moderate, fairly steady pace since then.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemia
JCI Insight · 2026
- Therapeutic Targeting of FLT3 Gate Keeper Mutation with E2082-0047 in Traditional and a Novel Immunocompetent Murine Adoptive Transfer Model of AML
Blood · 2023
- Antioxidant and pro-oxidant mechanisms of (+) catechin in microsomal CYP2E1-dependent oxidative stress
Toxicology in Vitro · 2018
- The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia
Oncotarget · 2017
- Blood×8
- Cancer Research×3
- Blood Advances×2
- JCI Insight×2
- Cancers×2
- Wenjie Cai
Medicine · Indiana University
- Junke Wang
Medicine · The Ohio State University
- Brian Giacopelli
Medicine · The Ohio State University
- Jean Truxall
Medicine · The Ohio State University
- Li Yu
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile